Our Science

Our Science
Surface is developing antibodies that target key components of the Tumor Microenvironment


Latest News

Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement

Get the details

Careers at Surface

Careers at Surface Oncology
Culture counts. Surface Oncology’s science isn’t the only thing that sets it apart.

Join Our Team